European Journal of Pharmacology 435 92002)
237 – 244
Polyglutamation of a novel antifolate, MX-68 is not necessary for its
anti-arthritic effect
Cellular Pharmacology (1996) 3; 29-34
Aldehyde Oxidase Mediated 7-Hydroxylation of Antifolates and its Therapeutic
Relevance
Journal Of Medicinal Chemistry, 1991
Folate Analogues, 34. Syntheseis and Antitumor Activity of Non-Polyglutamylatable
Inhibitors of Dihydrofolate Reductase
Medical Chemistry Research 9:3 (1999) 176-185
Metabolism Blocked Classical Folate Analog Inhibitors of Dihydrofolate
Reductase-1: Synthesis and Biological Evaluation of Mobiltrexx
Cancer Chemotherapy Pharmacology (1996) 37:
415-422
High-dose 7-hydroxymethotrexate: acute toxicity and lethality in a
rat model
Cancer Chemotherapy Pharmacology (1994) 34:
119-124 Renal and hepatic toxicity after high-dose 7-hydroxymehtotrexate
in the rat
Biochemical and Biophysical Research Communications,
Vol. 52, No. 1, 1973
Polygammaglutamyl Metabolites of Methotrexate
Cellular Pharmacology (1994) 1, 245-245
Polyglutamylation as a determinant of cytotoxicity of classical folate
analogue inhibitors of thymidylate synthase and glycinamided ribonucleotide
fomyltransferase
Clinical Cancer Research, Vol. 2, 707-712,
April 1996
Polyglutamylation of the Dihydrofolate Reductase Inhibitor Methylene-10-deazaaminopterin
Is Not Essential for Antitumor Activity
Pharmacology and Therapeutics in the New Millennium,
2001
Metabolism-Based Antifolate Drug Design: MDAM and MTRE
